Treatment success rate for patients treated for MDR-TB in Africa (WHO region)
Africa (WHO region): Treatment success rate for patients treated for MDR-TB was 74.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in Africa (WHO region), 2002–2022
Source: World Health Organization, Global Health Observatory.
Analysis
Africa (WHO region) recorded 74.0% for treatment success rate for patients treated for mdr-tb in 2022. That is the highest value across all 20 years on record.
Compared with earlier readings it is up 1.4% on the previous year and up 39.6% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Africa (WHO region) peaked at 74.0% in 2022 and was at its lowest, 43.0%, in 2003.
The long-run direction has been consistently rising across the 20 years of available data.
Treatment success rate for patients treated for MDR-TB in Africa (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2002 | 48.0% | — |
| 2003 | 43.0% | -10.4% |
| 2004 | 45.0% | +4.7% |
| 2006 | 65.0% | +44.4% |
| 2007 | 44.0% | -32.3% |
| 2008 | 50.0% | +13.6% |
| 2009 | 45.0% | -10.0% |
| 2010 | 46.0% | +2.2% |
| 2011 | 47.0% | +2.2% |
| 2012 | 53.0% | +12.8% |
| 2013 | 54.0% | +1.9% |
| 2014 | 59.0% | +9.3% |
| 2015 | 61.0% | +3.4% |
| 2016 | 60.0% | -1.6% |
| 2017 | 64.0% | +6.7% |
| 2018 | 69.0% | +7.8% |
| 2019 | 71.0% | +2.9% |
| 2020 | 71.0% | +0.0% |
| 2021 | 73.0% | +2.8% |
| 2022 | 74.0% | +1.4% |
Biggest year-on-year movements
Years where Treatment success rate for patients treated for MDR-TB in Africa (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2006 | +44.4% | 45.0% | 65.0% |
| 2007 | -32.3% | 65.0% | 44.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 48.6% | 43.0% | 65.0% | 7 |
| 2010s | 58.4% | 46.0% | 71.0% | 10 |
| 2020s | 72.7% | 71.0% | 74.0% | 3 |
More health data for Africa (WHO region)
- Pertussis - number of reported cases, gaps filled 12,202 (2025)
- Total tetanus - number of reported cases, gaps filled 20,578 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1,654 (2025)
- Measles - number of reported cases, gaps filled 179,400 (2025)
- Diphtheria - number of reported cases, gaps filled 20,261 (2025)
- Number of under-five deaths, annual growth rate -1.43 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -0.0365 % change on previous year (2024)
- Number of infant deaths, annual growth rate -0.8695 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -8.02 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 160.28 % change on previous year (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Africa (WHO region)?
- Treatment success rate for patients treated for mdr-tb in Africa (WHO region) was 74.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Africa (WHO region)?
- The highest recorded value was 74.0% in 2022.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Africa (WHO region)?
- The lowest recorded value was 43.0% in 2003.
- How does Africa (WHO region) rank for treatment success rate for patients treated for mdr-tb?
- Africa (WHO region) ranks 5th out of 11 groups with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Africa (WHO region)?
- Over the last ten years it is up 39.6%. The long-run trend across the full record is rising.
- Where does this Africa (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).